Bone drug can prevent breast cancer
At least two million women might benefit from raloxifene's cancer-reducing effects, US researchers said.
Until now, the decades-old tamoxifen has been doctors' only choice to reduce the chances of breast cancer striking high-risk women.

 
			     
                     
                     
                     
  
  
  
  
  
 



